The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Early Inhaled Glucocorticoid Therapy to Prevent Bronchopulmonary Dysplasia
Open accessAbstract
BACKGROUND: The safety and efficacy of inhaled glucocorticoid therapy for asthma stimulated its use in infants to prevent bronchopulmonary dysplasia. We tested the hypothesis that early therapy with inhaled glucocorticoids would decrease the frequency of bronchopulmonary dysplasia in premature infants. METHODS: We conducted a randomized, multicenter trial of inhaled beclomethasone or placebo in 253 infants, 3 to 14 days old, born before 33 weeks of gestation and weighing 1250 g or less at birth, who required ventilation therapy. Beclomethasone was delivered in a decreasing dosage, from 40 to 5 microg per kilogram of body weight per day, for four weeks. The primary outcome measure was bronchopulmonary dysplasia at 28 days of age. Secondary outcomes included bronchopulmonary dysplasia at 36 weeks of postmenstrual age, the need for systemic glucocorticoid therapy, the need for bronchodilator therapy, the duration of respiratory support, and death. RESULTS: One hundred twenty-three infants received beclomethasone, and 130 received placebo. The frequency of bronchopulmonary dysplasia was similar in the two groups: 43 percent in the beclomethasone group and 45 percent in the placebo group at 28 days of age, and 18 percent in the beclomethasone group and 20 percent in the placebo group at 36 weeks of postmenstrual age. At 28 days of age, fewer infants in the beclomethasone group than in the placebo group were receiving systemic glucocorticoid therapy (relative risk, 0.6; 95 percent confidence interval, 0.4 to 1.0) and mechanical ventilation (relative risk, 0.8; 95 percent confidence interval, 0.6 to 1.0). CONCLUSIONS: Early beclomethasone therapy did not prevent bronchopulmonary dysplasia but was associated with lower rates of use of systemic glucocorticoid therapy and mechanical ventilation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discrete sequential boundaries for clinical trials
GORDON LAN, K. K., & DEMETS, D. L. (1983) · Biometrika · doi:10.1093/biomet/70.3.659 · Cited by 2,310
Cited by
Adverse Effects of Early Dexamethasone Treatment in Extremely-Low-Birth-Weight Infants
Stark, A. R., Carlo, W. A., Tyson, J. E., Papile, L.-A., Wright, L. L., Shankaran, S., Donovan, E. F., Oh, W., Bauer, C. R., Saha, S., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101113440203 · Cited by 479
Kinsella, J. P., Greenough, A., & Abman, S. H. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68615-7 · Cited by 454
Statement on the Care of the Child with Chronic Lung Disease of Infancy and Childhood
(2003) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.168.3.356 · Cited by 338
Hillier, S. C., Krishna, G., & Brasoveanu, E. (2004) · Seminars in Pediatric Surgery · doi:10.1053/j.sempedsurg.2004.04.002 · Cited by 32
Metadata
- Authors
- Cole, C. H., Colton, T., Shah, B. L., Abbasi, S., MacKinnon, B. L., Demissie, S., & Frantz, I. D.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 1999-04
- Volume
- 340
- Issue
- 13
- Pages
- 1005-1010
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2314661573
- Cited by
- 169
- References
- 1
- FWCI
- 13.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Early Inhaled Glucocorticoid Therapy to Prevent Bronchopulmonary Dysplasia. https://app.cochat.ai/papers/10.1056/nejm199904013401304
- The paper
- Cole, C. H., Colton, T., Shah, B. L., Abbasi, S., MacKinnon, B. L., Demissie, S., & Frantz, I. D. (1999). Early Inhaled Glucocorticoid Therapy to Prevent Bronchopulmonary Dysplasia. New England Journal of Medicine. https://doi.org/10.1056/nejm199904013401304
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.